The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial - Concepedia

Concepedia

Publication | Closed Access

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

194

Citations

55

References

2004

Year

Caryn Lerman, E. Paul Wileyto, Freda Patterson, Margaret Rukstalis, Janet Audrain‐McGovern, Stephanie Restine, Peter G. Shields, Vyga Kaufmann, David T. Redden, Neal L. Benowitz,

The Pharmacogenomics Journal

Opioid EpidemicMolecular PharmacologyAddictionNicotinePharmacologyNeuropharmacologyPharmacotherapyMedicineShort-term ResponseOpioid Use DisorderReplacement TherapyHealth Sciences

References

	Year	Citations

Page 1

Page 1